A new tubulin polymerization inhibitor, auristatin PE, induces tumor regression in a human Waldenstrom's macroglobulinemia xenograft model.

International journal of oncology

Volumn 15, Issue 2, 1999, Pages 367-372

  Mohammad, R M ^a   Limvarapuss, C ^a   Wall, N R ^a   Hamdy, N ^a   Beck, F W ^a   Pettit, G R ^a   Al Katib, A ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BIOPOLYMER; OLIGOPEPTIDE; SOBLIDOTIN; TUBULIN;

ANIMAL; APOPTOSIS; ARTICLE; CELL DIVISION; COMBINED IMMUNODEFICIENCY; DISEASE MODEL; DRUG EFFECT; FLOW CYTOMETRY; HUMAN; METHODOLOGY; MIDDLE AGED; MITOSIS; MOUSE; MOUSE MUTANT; REMISSION; WALDENSTROEM MACROGLOBULINEMIA; XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BIOPOLYMERS; CELL DIVISION; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; HUMANS; MICE; MICE, SCID; MIDDLE AGED; MITOSIS; OLIGOPEPTIDES; REMISSION INDUCTION; SEVERE COMBINED IMMUNODEFICIENCY; TRANSPLANTATION, HETEROLOGOUS; TUBULIN; WALDENSTROM MACROGLOBULINEMIA;

MLCS; MLOWN;

EID: 0033174893     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.15.2.367     Document Type: Article

References (0)